16 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Development of substrate analogue inhibitors for the human airway trypsin-like protease HAT.
Philipps University Marburg
From N-0385 to N-0920: Unveiling a Host-Directed Protease Inhibitor with Picomolar Antiviral Efficacy against Prevalent SARS-CoV-2 Variants.
University of Sherbrooke
Novel compounds with dual inhibition activity against SARS-CoV-2 critical enzymes RdRp and human TMPRSS2.
University of Sharjah
Design, synthesis and biological evaluation of biaryl amide derivatives against SARS-CoV-2 with dual-target mechanism.
Chinese Academy of Medical Sciences and Peking Union Medical College
Mechanism-Based Macrocyclic Inhibitors of Serine Proteases.
Washington University School of Medicine
Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors.
National Clinical Research Center for Geriatrics
New Strategies for Responding to SARS-CoV-2: The Present and Future of Dual-Target Drugs.
China Pharmaceutical University
Enzyme inhibition as a potential therapeutic strategy to treat COVID-19 infection.
Kingston University
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
South China Agricultural University
